Market Research Logo

AstraZeneca Plc - Product Pipeline Review - 2016

AstraZeneca Plc - Product Pipeline Review - 2016

Summary



Global Markets Direct’s, ‘AstraZeneca Plc - Product Pipeline Review - 2016’, provides an overview of the AstraZeneca Plc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by AstraZeneca Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of AstraZeneca Plc
  • The report provides overview of AstraZeneca Plc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses AstraZeneca Plc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features AstraZeneca Plc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate AstraZeneca Plc’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for AstraZeneca Plc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding AstraZeneca Plc’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


AstraZeneca Plc Snapshot
AstraZeneca Plc Overview
Key Information
Key Facts
AstraZeneca Plc - Research and Development Overview
Key Therapeutic Areas
AstraZeneca Plc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Pipeline Products - Out-Licensed Products
AstraZeneca Plc - Pipeline Products Glance
AstraZeneca Plc - Late Stage Pipeline Products
AstraZeneca Plc - Clinical Stage Pipeline Products
AstraZeneca Plc - Early Stage Pipeline Products
AstraZeneca Plc - Drug Profiles
(avibactam + ceftazidime)
(dapagliflozin propanediol + saxagliptin)
(formoterol fumarate + glycopyrrolate)
(metformin hydrochloride + saxagliptin)
brodalumab
cangrelor tetrasodium
cediranib maleate
ceftaroline fosamil
dapagliflozin propanediol
osimertinib mesylate
propofol
ticagrelor
(aclidinium bromide + formoterol fumarate)
(budesonide + formoterol fumarate + glycopyrrolate)
(dapagliflozin propanediol + metformin hydrochloride + saxagliptin)
fulvestrant
gefitinib
glycopyrrolate
olaparib
omega-3-carboxylic acids
PT-009
quetiapine fumarate ER
roxadustat
selumetinib sulfate
AZD-3293
AZD-4547
(avibactam sodium + ceftaroline fosamil)
abediterol napadisylate
AZD-1775
AZD-1981
AZD-2014
AZD-3241
AZD-3759
AZD-4017
AZD-5363
AZD-7594
AZD-7624
AZD-9150
interferon beta-1a
lesogaberan
PT-008
RDEA-3170
sapitinib
saracatinib difumarate
savolitinib
Small Molecule for Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
AZD-5069
AZD-5312
(allopurinol + lesinurad)
(avibactam sodium + aztreonam lysine)
(insulin human + pramlintide acetate)
ARC-165395XX
AZD-0156
AZD-0424
AZD-3965
AZD-4076
AZD-5634
AZD-5718
AZD-6738
AZD-7451
AZD-7986
AZD-8108
AZD-8186
AZD-8835
AZD-8871
AZD-8999
AZD-9496
AZD-9567
dabrafenib mesylate + durvalumab + trametinib dimethyl sulfoxide
LAS-40468
MEDI-7352
AC-163794
ADP-31417
ADP-71296
AZ-12260493
AZ-12441970
AZ-12861903
AZ-13483342
AZ-20
AZ-4217
AZ-4425
AZ-64
AZ-709
AZ-876
AZD-0449
AZD-2098
AZD-2858
AZD-3463
AZD-3857
AZD-4831
AZD-9708
CWGNC-41
Drug 1 for Cancer
Drug 2 for Cancer
Drug 3 for Cancer
Drug 4 for Cancer
Drug 5 for Cancer
Drug 6 for Cancer
HTL-1071
KU-59403
LAS-191351
LAS-194871
LCB-010200
MMV-253
Monoclonal Antibody Conjugates for Oncology
NBTI-5463
NKTR-119
OX-CLI
PL-8905
Small Molecule for Malaria
Small Molecule for Oncology
Small Molecule to Antagonize Histamine 3 Receptor for Cognition
Small Molecule to Antagonize Sphingosine 1 Phosphate Receptor 1 for Oncology
Small Molecule to Block Kv1.5 for Atrial Fibrillation
Small Molecule to Inhibit DNA Gyrase for Streptococcal Pneumonia
Small Molecule to Inhibit PI3K Beta for Bleeding and Clotting Disorders
Small Molecule to Inhibit Xanthine Oxidase for Hyperuricemia
Small Molecules 1 for Malaria
Small Molecules for Dyslipidemia and Hypertriglyceridemia
Small Molecules to Antagonize GPR103 for Obesity
Small Molecules to Antagonize M3 Receptors for Respiratory Disorders
Small Molecules to Antagonize P2X3 for Chronic Pain
Small Molecules to Inhibit CDK9 for Inflammatory Pain and Rheumatoid Arthritis
Small Molecules to Inhibit DNA GyrB for Tuberculosis
Small Molecules to Inhibit DprE1 for Tuberculosis
Synthetic Peptide for Neuropathic Pain
VU-0467154
AZ-0108
AZ-12201182
AZ-27
AZ-465
AZ-6142
AZ-82
AZD-3147
Drugs for Cardiovascular Diseases
HD-001
Small Molecule 1 for Malaria
Small Molecule to Inhibit 11beta-HSD-1 for Type 2 Diabetes
Small Molecule to Inhibit Src Tyrosine Kinase for Lymphangioleiomyomatosis
Small Molecules for Diabetic Nephropathy
Small Molecules for Tuberculosis
Small Molecules to Inhibit Acetohydroxyacid Synthase for Mycobacterium Infections
Small Molecules to Inhibit ATP Synthesis for Tuberculosis
Small Molecules to Inhibit Carboxypeptidase U for Thrombosis
Small Molecules to Inhibit DNA Gyrase B for Tuberculosis
Small Molecules to Inhibit DXP-Reductoisomerase for Malaria
Small Molecules to Inhibit MALT-1 for Oncology and Autoimmune Disorders
Small Molecules to Inhibit p38alpha MAP Kinase for Inflammatory Diseases
Small Molecules to Inhibit PLA2 for Undisclosed Indication
AstraZeneca Plc - Pipeline Analysis
AstraZeneca Plc - Pipeline Products by Target
AstraZeneca Plc - Pipeline Products by Route of Administration
AstraZeneca Plc - Pipeline Products by Molecule Type
AstraZeneca Plc - Pipeline Products by Mechanism of Action
AstraZeneca Plc - Recent Pipeline Updates
AstraZeneca Plc - Dormant Projects
AstraZeneca Plc - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
AstraZeneca Plc - Company Statement
AstraZeneca Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
AstraZeneca Plc - Key Manufacturing Facilities
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
AstraZeneca Plc, Key Information
AstraZeneca Plc, Key Facts
AstraZeneca Plc - Pipeline by Indication, 2016
AstraZeneca Plc - Pipeline by Stage of Development, 2016
AstraZeneca Plc - Monotherapy Products in Pipeline, 2016
AstraZeneca Plc - Combination Treatment Modalities in Pipeline, 2016
AstraZeneca Plc - Partnered Products in Pipeline, 2016
AstraZeneca Plc - Partnered Products/ Combination Treatment Modalities, 2016
AstraZeneca Plc - Out-Licensed Products in Pipeline, 2016
AstraZeneca Plc - Out-Licensed Products/ Combination Treatment Modalities, 2016
AstraZeneca Plc - Pre-Registration, 2016
AstraZeneca Plc - Filing rejected/Withdrawn, 2016
AstraZeneca Plc - Phase III, 2016
AstraZeneca Plc - Phase II, 2016
AstraZeneca Plc - Phase I, 2016
AstraZeneca Plc - Preclinical, 2016
AstraZeneca Plc - Discovery, 2016
AstraZeneca Plc - Pipeline by Target, 2016
AstraZeneca Plc - Pipeline by Route of Administration, 2016
AstraZeneca Plc - Pipeline by Molecule Type, 2016
AstraZeneca Plc - Pipeline Products by Mechanism of Action, 2016
AstraZeneca Plc - Recent Pipeline Updates, 2016
AstraZeneca Plc - Dormant Developmental Projects,2016
AstraZeneca Plc - Discontinued Pipeline Products, 2016
AstraZeneca Plc, Subsidiaries
AstraZeneca Plc, Key Manufacturing Facilities
List of Figures
AstraZeneca Plc - Pipeline by Top 10 Indication, 2016
AstraZeneca Plc - Pipeline by Stage of Development, 2016
AstraZeneca Plc - Monotherapy Products in Pipeline, 2016
AstraZeneca Plc - Combination Treatment Modalities in Pipeline, 2016
AstraZeneca Plc - Partnered Products in Pipeline, 2016
AstraZeneca Plc - Out-Licensed Products in Pipeline, 2016
AstraZeneca Plc - Pipeline by Top 10 Target, 2016
AstraZeneca Plc - Pipeline by Route of Administration, 2016
AstraZeneca Plc - Pipeline by Molecule Type, 2016
AstraZeneca Plc - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report